Recombinant Human Growth Hormone Plus Recombinant Human Insulin-Like Growth Factor-1 Coadministration Therapy in Short Children with Low Insulin-Like Growth Factor-1 and Growth Hormone Sufficiency: Results from a Randomized, Multicenter, Open-Label, Parallel-Group, Active Treatment-Controlled Trial

Publisher： Karger

E-ISSN： 1663-2826|83|4|268-279

ISSN： 1663-2818

Source： Hormone Research in Paediatrics, Vol.83, Iss.4, 2015-03, pp. : 268-279

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Further Observations on the Effects of Long-Term Treatment with Recombinant Human Insulin-Like Growth Factor 1 in Growth Hormone Insensitivity Syndrome

By  

Hormone Research in Paediatrics, Vol. 81, Iss. 4, 2014-03 ,pp. : 258-265

Karger

Access to resources Recommend Favorite

Pharmacodynamic Considerations with Recombinant Human Insulin-Like Growth Factor-I in Children

By  

Hormone Research in Paediatrics, Vol. 63, Iss. 5, 2005-07 ,pp. : 220-227

Karger

Access to resources Recommend Favorite

Treatment with Recombinant Human Insulin-Like Growth Factor-1 in Severe Primary IGF Deficiency and Beyond

By  

Hormone Research in Paediatrics, Vol. 83, Iss. 5, 2015-04 ,pp. : 358-360

Karger

Access to resources Recommend Favorite

Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency

By  

Hormone Research in Paediatrics, Vol. 86, Iss. 6, 2016-11 ,pp. : 361-397

Karger

Access to resources Recommend Favorite

Principles of Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children with Idiopathic Short Stature

By  

Hormone Research in Paediatrics, Vol. 76, Iss. 3, 2011-09 ,pp. : 24-26

Karger

Access to resources Recommend Favorite